Albireo Pharma Inc Ratio court
Quel est le Ratio court de Albireo Pharma Inc?
Le Ratio court de Albireo Pharma Inc est 5.09
Quelle est la définition de Ratio court?
Le ratio court des actions vendues est le nombre d'actions vendues à découvert divisé par le volume quotidien moyen.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Ratio court des entreprises dans Health Care secteur sur NASDAQ par rapport à Albireo Pharma Inc
Que fait Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Entreprises avec ratio court similaire à Albireo Pharma Inc
- Surface Oncology Inc a Ratio court de 5.08
- Rice Acquisition a Ratio court de 5.08
- SmartCentres Real Estate Investment Trust a Ratio court de 5.08
- The Lion Electric a Ratio court de 5.08
- QIWI plc a Ratio court de 5.08
- Super Micro Computer Inc a Ratio court de 5.08
- Albireo Pharma Inc a Ratio court de 5.09
- Neogenomics a Ratio court de 5.10
- Medpace Inc a Ratio court de 5.10
- Wesbanco a Ratio court de 5.10
- Auq Gold Mining Inc a Ratio court de 5.10
- Marriott Vacations Worldwide Corp a Ratio court de 5.10
- Johnson Outdoors Inc a Ratio court de 5.10